Clinical Trial Update: Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes

View source ↗

Summary

This entry reports the completion of an observational study evaluating the safety of Levemir (insulin detemir) in patients with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED